NextTrip, Inc. — Director's Dealing 2022

Jul 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGMA LABS, INC. (SASI)
CIK: 0000788611
Period of Report: 2022-07-01

Reporting Person: Brunsberg Jacob (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-01	Stock Option (right to buy)	$2.50	A	49800	Acquired	2027-07-01	Common Stock (49800)	Direct
2022-07-01	Stock Appreciation Right	$1.30	A	121298	Acquired	2027-07-01	Common Stock (121298)	Direct
2022-07-01	Stock Appreciation Right	$2.50	A	194940	Acquired	2027-07-01	Common Stock (194940)	Direct

Footnotes

F1: The stock option vests, as follows: (i) 12,450 shares subject to the option vested on the date of grant, and (ii) the remaining 37,350 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.

F2: The stock appreciation right ("SAR") is payable in cash only, and vests on March 15, 2025, subject to the Reporting Person being in the continuous employ of the Issuer on the vesting date.

F3: The SAR is payable in cash only and vests as follows: (i) 25% of the SAR vested on the date of grant, and (ii) the balance of the SAR will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.